Through a case presentation, as well as upcoming studies and rationale for the Food and Drug Administration, the aim of this session is to help you answer the following questions: how can the use of a sirolimus-coated DCB be expanded in new and challenging treatment indications? Why is sirolimus-coated balloon the ideal choice in native vessel disease treatment? What does the future hold for sirolimus-coated balloons?

With Patrick W. Serruys, Azeem Latib, Praveen Chandra, Antonio Colombo, Bernardo Cortese, Sameer Dani, Aloke Finn, and Damiano Regazzoli.

Sponsored by Concept Medical Inc.

Find more content from EuroPCR 2022 here: [ Ссылка ]

#EuroPCR
#CAD
#SirolimusCoatedBalloon

свернуть